4//SEC Filing
ATHENAHEALTH INC 4
Accession 0001131096-17-000081
CIK 0001131096operating
Filed
May 15, 8:00 PM ET
Accepted
May 16, 7:31 PM ET
Size
5.5 KB
Accession
0001131096-17-000081
Insider Transaction Report
Form 4
ATHENAHEALTH INCATHN
O'Brien Timothy John
SVP, Chief Marketing Officer
Transactions
- Sale
Common Stock
2017-05-12$107.02/sh−3,398$363,654→ 11,035 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 13, 2017, in accordance with Rule 10b5-1.
- [F2]Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.95 to $107.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote (2).
- [F3]The securities reported in this Column 5 are units of common stock granted pursuant to Restricted Stock Unit ("RSU") awards under the athenahealth, Inc. 2007 Stock Option and Incentive Plan, as amended and restated. The RSUs are subject to time-based vesting and will be settled only in stock.
Documents
Issuer
ATHENAHEALTH INC
CIK 0001131096
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001131096
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 7:31 PM ET
- Size
- 5.5 KB